Fig. 3

[18F]-FDG uptake changes before and 3 months after the initiation of antifibrotic drugs. a Different PET parameters were calculated (SUVmean, SUVmean corrected for the lung density - SUVmean-corr, SUVmax, metabolic lung volume -MLV, total lung glycolysis -TLG, target-to-background ratio -TBR) before and three months after the initiation of a treatment by pirfenidone or nintedanib. Data on graph correspond to the pooled results obtained with both antifibrotic drugs and consist of the median with whiskers corresponding to the percentile 10–90. b Individual changes in SUVmean-corr detailed for patients on pirfenidone (white boxes) and nintedanib (black squares). c The detailed changes in SUVmean-corr for patients on pirfenidone and nintedanib. Data on graph correspond to the median with whiskers corresponding to the percentile 10–90